Head to head
Lindus Health vs TrialSpark
Bundled fixed-price CRO versus technology-led execution.
Lindus Health
TrialSpark
Model
Lindus Health
CRO with recruitment armTrialSpark
CRO with recruitment armIn one line
Lindus Health
All-in-one CRO bundling recruitment, sites, and eClinical with fixed pricing.TrialSpark
Technology-led trial execution; strategy has shifted toward drug development.What they do
Lindus Health
Sells the full study as one package — recruitment, site services, and its own eClinical software — pitched against traditional CROs on cost transparency and speed, often with fixed-price or outcome-linked contracting.TrialSpark
Built a technology-driven model for running trials with an emphasis on speed and data infrastructure. Note that its corporate focus has moved substantially toward in-house drug development, so confirm current service availability before shortlisting.Pricing
Lindus Health
Fixed-price study contracts; unusually explicit about this compared with peers.TrialSpark
Study-scoped; confirm current commercial model directly.Strengths
Lindus Health
- One accountable party for enrollment instead of a CRO/vendor blame loop
- Fixed pricing removes change-order exposure
- Own technology stack reduces integration lag
TrialSpark
- Strong technology and data engineering foundations
Watch for
Lindus Health
- Younger organization than incumbent CROs; check therapeutic-area references
- Bundling means switching one component later is harder
TrialSpark
- Verify that trial-services work is still actively sold before spending RFP time
- Strategic pivots make multi-year commitments riskier
Best for
Lindus Health
Small and mid-size biotechs who want a single throat to choke on timelines.TrialSpark
Sponsors specifically evaluating technology-led execution models.Poor fit
Lindus Health
Sponsors already locked into a preferred-CRO relationship.TrialSpark
Anyone who needs certainty of vendor continuity across a long program.When Lindus Health is the right call
Pick Lindus Health when you want one contract covering CRO services, sites, and recruitment, with pricing that does not reprice every time the protocol shifts.
When TrialSpark is the right call
Pick TrialSpark when its technology and site model align with your indication and you would rather buy execution capability than a full bundled service.
How to actually decide
Bundling removes finger-pointing between CRO and recruitment vendor, which is a real advantage on a study already behind. It also removes your ability to replace one part without renegotiating everything. Ask each what happens contractually if enrollment misses plan by 40 percent at month six — the answer tells you more than the capability deck.
Do not pick on capability decks. Give both the same brief — your protocol, your countries, your screen failure assumptions — and ask each for the referral-to- randomization ratio they achieved on the three most similar studies they have run. Then price both on cost per randomized patient. The comparison usually resolves itself at that point, and often reveals that neither is the problem: the enrollment assumptions in the protocol were wrong from the start.
Our sister publication Rock Enroll covers that diagnosis in depth for sponsors and CRO teams.